Table 2.
Percentage of Subjects Rarely or Never Needing Glasses | Percentage Reporting “Good” or “Very Good” Vision without Glasses | ||||
---|---|---|---|---|---|
Condition | Current | Vivity SSE* | Current | Vivity SSE* | |
Overall | 70 | 45.1 | |||
Bright Light | Distance (“far away”) | 85 | 94.1 | 85 | 93.7 |
Intermediate (“arm’s length”) | 85 | 87.2 | 94 | 91.6 | |
Near (“up close”) | 73 | 46.1 | 70 | 57.3 | |
Dim Light | Distance (“far away”) | 85 | 93.2 | 79 | 87.5 |
Intermediate (“arm’s length”) | 88 | 84.3 | 76 | 83.4 | |
Near (“up close”) | 58 | 39.2 | 52 | 37.5 |
Notes: *PMA P930014/S126: FDA Summary of Safety and Effectiveness Data from US FDA. AcrySof™ IQ Vivity™ extended vision Intraocular Lens (IOL): Summary of safety and effectiveness data. Available from: https://www.accessdata.fda.gov/cdrh_docs/pdf/P930014S126B.pdf. Tables 32,33 6M.19